These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24914094)

  • 1. Anti-viral drugs in flu: not that good?
    Arch Dis Child; 2014 Aug; 99(8):766. PubMed ID: 24914094
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2012 Jan; 54(1381):1-3. PubMed ID: 22233587
    [No Abstract]   [Full Text] [Related]  

  • 4. Do we need a replacement medication for influenza with good efficacy?
    Arastoo M; Khorshid HR
    Daru; 2014 Dec; 22(1):84. PubMed ID: 25523212
    [No Abstract]   [Full Text] [Related]  

  • 5. Which agents should we use to treat and prevent influenza in 2006-2007?
    Mossad SB
    Cleve Clin J Med; 2006 Nov; 73(11):1016-8. PubMed ID: 17128543
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuraminidase inhibitors: effects still unclear].
    Gillissen A
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2086. PubMed ID: 23033163
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
    AIDS Alert; 2009 Jun; 24(6):69-70. PubMed ID: 19544608
    [No Abstract]   [Full Text] [Related]  

  • 8. Multisystem failure: the story of anti-influenza drugs.
    Jefferson T; Doshi P
    BMJ; 2014 Apr; 348():g2263. PubMed ID: 24721793
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse events of prophylactic anti-influenza agents in medical staffs.
    Kato H; Hagihara M; Kato Y; Kurumiya A; Takahashi T; Sakata M; Nishiyama N; Asai N; Koizumi Y; Furui T; Yamagishi Y; Mikamo H
    J Infect Chemother; 2017 Oct; 23(10):683-686. PubMed ID: 28781099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter.
    Blanchon T; Mentré F; Charlois-Ou C; Dornic Q; Mosnier A; Bouscambert M; Carrat F; Duval X; Enouf V; Leport C;
    Clin Microbiol Infect; 2013 Feb; 19(2):196-203. PubMed ID: 22264308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influenza in children: what should be considered in prevention and treatment?].
    Panknin HT; Trautmann M
    Kinderkrankenschwester; 2008 Feb; 27(2):61-4. PubMed ID: 18380419
    [No Abstract]   [Full Text] [Related]  

  • 13. Swine flu outbreak. What role for antiviral drugs?
    Couzin-Frankel J
    Science; 2009 May; 324(5928):705. PubMed ID: 19423784
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral drugs for influenza 2012-2013.
    Med Lett Drugs Ther; 2012 Dec; 54(1405):97-8. PubMed ID: 23223245
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to neuraminidase inhibitors.
    Dolin R
    Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drugs for influenza 2013-2014.
    Med Lett Drugs Ther; 2014 Jan; 56(1434):6-8. PubMed ID: 24457560
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
    Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
    Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.